Page last updated: 2024-08-24

gemcitabine and hymecromone

gemcitabine has been researched along with hymecromone in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, XY; Chen, Y; Feng, P; Guo, YL; Huang, YQ; Liu, MM; Yang, G	1
Kakizaki, I; Kon, A; Kudo, D; Morohashi, H; Nakazawa, H; Sasaki, M; Takagaki, K; Yoshihara, S	1

Other Studies

2 other study(ies) available for gemcitabine and hymecromone

Article	Year
Hybrids of phenylsulfonylfuroxan and coumarin as potent antitumor agents. Journal of medicinal chemistry, 2014, Nov-26, Volume: 57, Issue:22 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinogenesis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Coumarins; Drug Combinations; Drug Screening Assays, Antitumor; Female; HeLa Cells; Human Umbilical Vein Endothelial Cells; Humans; Inhibitory Concentration 50; MAP Kinase Kinase 1; Mice; Mice, Inbred BALB C; Mice, Nude; Mitogen-Activated Protein Kinase 3; Neoplasms; Nitric Oxide; Oxadiazoles; Signal Transduction	2014
4-methylumbelliferone, a hyaluronan synthase suppressor, enhances the anticancer activity of gemcitabine in human pancreatic cancer cells. Cancer chemotherapy and pharmacology, 2006, Volume: 57, Issue:2 Topics: Animals; Antimetabolites, Antineoplastic; Deoxycytidine; Drug Interactions; Gemcitabine; Humans; Hymecromone; Male; Mice; Mice, SCID; Pancreatic Neoplasms; Transplantation, Heterologous; Tumor Cells, Cultured	2006

Article

Year

Hybrids of phenylsulfonylfuroxan and coumarin as potent antitumor agents.

Journal of medicinal chemistry, 2014, Nov-26, Volume: 57, Issue:22

Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinogenesis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Coumarins; Drug Combinations; Drug Screening Assays, Antitumor; Female; HeLa Cells; Human Umbilical Vein Endothelial Cells; Humans; Inhibitory Concentration 50; MAP Kinase Kinase 1; Mice; Mice, Inbred BALB C; Mice, Nude; Mitogen-Activated Protein Kinase 3; Neoplasms; Nitric Oxide; Oxadiazoles; Signal Transduction

2014

4-methylumbelliferone, a hyaluronan synthase suppressor, enhances the anticancer activity of gemcitabine in human pancreatic cancer cells.

Cancer chemotherapy and pharmacology, 2006, Volume: 57, Issue:2

Topics: Animals; Antimetabolites, Antineoplastic; Deoxycytidine; Drug Interactions; Gemcitabine; Humans; Hymecromone; Male; Mice; Mice, SCID; Pancreatic Neoplasms; Transplantation, Heterologous; Tumor Cells, Cultured

2006